So, it needs to be studied whether ADT promotes BACE1 expression in the neurons, and, potentially, BACE1 inhibitor/s could be useful in preventing dementia development in PCa patients, along with reducing tumor burden. This evidence concerns the gene BACE1 and posterior cortical atrophy.